Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.45001 | 17 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.41271 | 17 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.41491 | 17 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.35848 | 17 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.35521 | 16 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.46594 | 17 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.50371 | 20 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.38982 | 17 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.3811 | 17 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.39814 | 17 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.39896 | 17 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.38252 | 17 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.40587 | 17 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.40236 | 17 |